亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。

返回搜索结果

RNA-based Ovarian Cancer Diagnostic

技术优势: Advantages of this approach include the ability to: detect ovarian cancer in the asymptomatic phase of the disease;use tissue samples that are routinely collected in a gynecologic exam; anddetect at high sensitivity (a few tumor cells).

详细技术说明: UC Inventors have discovered a number of mRNA transcripts that are selectively expressed in ovarian tumors and may be used to detect the presence of an ovarian tumor in a Pap smear and/or endometrial biopsy.

*Abstract: Ovarian cancer is the fifth leading cause of cancer death among women in the US and the poor prognosis is related to the reality that the disease is not usually detected until a patient is in the advanced stages of the disease. Because there is an unmet need, some markers (e.g., Cancer Antigen 125 (CA125) and human epididymis protein 4 (HE4)) are being investigated for their ability to monitor ovarian cancer but there is no available test that has proven to be effective for early detection of the disease. There remains a need for predictive biomarkers that are able to reliably detect disease in the asymptomatic phase.

*Principal Investigation: Name: Christian Barrett
Department:

Name: Dennis Carson
Department:

Name: Kelly Frazer
Department:

其他: State Of Development
A number of ovarian tumor-specific transcripts have been identified and relevant primers developed. Work is continuing to identify additional tumor-specific transcripts and to optimize primers for detection in the relevant tissues.

Intellectual Property Info
Worldwide rights available; Pending patents available under confidentiality.

Related Materials
Cramer et al., Ovarian cancer biomarker performance in prostate, lung, colorectral, and ovarian cancer screening trial specimens, 2011; Cancer Prev Res (Phila), 4(3):365-74.
Zhu et. al., A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer, 2011, Cancer Prev Res (Phila), 4(3):375-83

Tech ID/UC Case
24303/2014-349-0

Related Cases
2014-349-0

欲了解更多信息，请点击这里